Document is current
Any future updates will be listed below
-
Authors
Kosugi, Takaaki https://orcid.org/0000-0003-3696-2263
Hasegawa, Takeshi
Imaizumi, Takahiro
Nishiwaki, Hiroki
Honda, Hirokazu
Ito, Yasuhiko
Tsuruya, Kazuhiko
Abe, Masanori
Hanafusa, Norio
Kuragano, Takahiro
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (24K06239)
- License Information
-
More Information
Article History
Received: 25 September 2024
Accepted: 20 January 2025
First Online: 11 February 2025
Declarations
:
: TKo has no conflicts of interest to disclose. TH has no conflicts of interest to disclose. TI received honoraria from GSK. HN has no conflicts of interest to disclose. HH received honoraria from Astellas, Bayer, Chugai, Kissei, Kyowa Kirin, Mitsubishi Tanabe, and Torii. YI received honoraria from Chugai, Kyowa Kirin, Astellas, Mitsubishi Tanabe, Bayer, and Torii. KT received honoraria from Kyowa Kirin, Mitsubishi Tanabe, Astellas, Torii, Bayer, and Chugai and donations from Kyowa Kirin, and Bayer. MA received honoraria from Kyowa Kirin, Bayer Yakuhin, Torii Pharmaceutical, Astellas Pharma, and Mitsubishi Tanabe Pharma. NH has no conflicts of interest to disclose. TKu received research grants from Ono and Kissei and speaker bureaus from Kyowa Kirin, Fuso, Mitsubishi Tanabe, Astellas, AstraZeneca, and Bayer.
: This study was approved by the Medicine Ethics Committee of JSDT (approved No. 63) and was conducted in accordance with the Declaration of Helsinki and Ethical Guidelines for Medical and Biological Research Involving Human Subjects issued in March 2022 by the Ministry of Health, Labour and Welfare and the Ministry of Education, Culture, Sports, Science and Technology.
: Written consent for participation was waived by the Ethics Committee due to the use of anonymized data, the absence of intervention conducted for research purposes, and the provision of the option to decline participation (opt-out).
